Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


03.09.2018

3 Blood
1 Br J Haematol
1 Cancer Lett
1 J Clin Oncol
1 Leuk Lymphoma
3 Oncology (Williston Park)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. SHIMADA K, Hayakawa F, Kiyoi H
    Biology and management of primary effusion lymphoma.
    Blood. 2018 Aug 28. pii: blood-2018-03-791426. doi: 10.1182/blood-2018-03-791426
    PubMed     Text format     Abstract available

  2. KOBE C, Goergen H, Baues C, Kuhnert G, et al
    Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
    Blood. 2018 Aug 30. pii: blood-2018-05-852129. doi: 10.1182/blood-2018-05-852129
    PubMed     Text format     Abstract available

  3. MADDOCKS K
    Update on Mantle Cell Lymphoma.
    Blood. 2018 Aug 28. pii: blood-2018-03-791392. doi: 10.1182/blood-2018-03-791392
    PubMed     Text format     Abstract available


    Br J Haematol

  4. WALEWSKI J, Hellmann A, Siritanaratkul N, Ozsan GH, et al
    Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
    Br J Haematol. 2018 Aug 30. doi: 10.1111/bjh.15539.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. QU C, Kunkalla K, Vaghefi A, Frederiksen JK, et al
    Smoothened Stabilizes and Protects TRAF6 from Degradation: A Novel Non-Canonical Role of Smoothened with Implications in Lymphoma Biology.
    Cancer Lett. 2018 Aug 27. pii: S0304-3835(18)30538.
    PubMed     Text format     Abstract available


    J Clin Oncol

  6. YANG JC, Yahalom J
    Early-Stage Follicular Lymphoma: What Is the Preferred Treatment Strategy?
    J Clin Oncol. 2018 Aug 28:JCO2018793075. doi: 10.1200/JCO.2018.79.3075.
    PubMed     Text format    


    Leuk Lymphoma

  7. WALEWSKI J, Paszkiewicz-Kozik E, Borsaru G, Hellmann A, et al
    Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study.
    Leuk Lymphoma. 2018 Aug 30:1-10. doi: 10.1080/10428194.2018.1492122.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  8. NASTOUPIL LJ
    Point: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
    Oncology (Williston Park). 2018;32:404-7.
    PubMed     Text format    

  9. BARR PM
    Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
    Oncology (Williston Park). 2018;32:404.
    PubMed     Text format    

  10. ZING NPC, Fischer T, Zain J, Federico M, et al
    Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
    Oncology (Williston Park). 2018;32:e83-e89.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: